Login to Your Account

Lilly moves into hearing loss via Audion investment

By Cormac Sheridan
Staff Writer

Monday, February 10, 2014
Eli Lilly and Co. entered the hearing loss field, by investing in a Series A round at Audion Therapeutics BV and supplying a series of compounds, including its γ-secretase inhibitors, to test their potential in hair cell regeneration.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription